Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Learn about credit cards that offer cash back without an annual fee. Make an informed decision to boost your savings.
27,601 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Space and defense investing offers two distinct paths. This guide compares First Trust MISL and ARKX, breaking down c...
A veteran market observer argues that timing the market is a losing bet. New data shows the cost of waiting and the b...
Markets extended their rally into a eight-week stretch, with the S&P 500 and Dow hitting fresh highs. This piece brea...
A JPMorgan Private Bank view argues that the 2026 rally is driven by earnings strength, with a base-case S&P 500 arou...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
A historic 93% one-day rally in a well-known automaker set a record for the largest single-day stock gain, prompting ...
Prediction-market odds now place bitcoin's year-end odds reaching 10%. This article breaks down what that means for y...
Keysight's Q2 2026 earnings transcript sheds light on demand, margins, and strategic priorities. This guide decodes t...
Oil prices jump as geopolitical tensions intensify, setting up a potential upside for select energy stocks. Three nam...
When Nvidia posts a blowout quarter, investors often wonder if the stock remains a smart buy. This article weighs his...
Regulators across Africa are shifting from bans to licensing, turning crypto into key remittance rails and reshaping ...